Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

The primary purpose of this study is to explore the safety and tolerability of AZD4547 in Japanese patients with advanced solid malignancies.

Phase 1

AstraZeneca